A follow-on Safety Study of CDP870 in Subjects With Crohn's Disease (CD) Who Have Completed a 26-week Double Blind Study CDP870-031 [NCT00152490] or CDP870-032 [NCT00152425]

Name: A follow-on Safety Study of CDP870 in Subjects With Crohn's Disease (CD) Who Have Completed a 26-week Double Blind Study CDP870-031 [NCT00152490] or CDP870-032 [NCT00152425]
Published: 2004
License: Public Domain

UCB Pharma SA · 2004

ClinicalTrials.gov · Datasets · License: Public Domain · 2004

Open Source ↗

crohn-s-disease

crohn's disease, certolizumab pegol, cimzia, cdp870, czp, interventional, phase3

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

A follow-on Safety Study of CDP870 in Subjects With Crohn's Disease (CD) Who Have Completed a 26-week Double Blind Study CDP870-031 [NCT00152490] or CDP870-032 [NCT00152425]

Related documents